Pro Medicus Limited (PME.AX) Comparison with companies in other sectors?

Pro Medicus Limited has a share price of 104.46M. You can analyze Pro Medicus Limited (PME.AX) competitors across different market sectors through stock heatmaps.

What are PME.AX's NET and operating margins?

Pro Medicus Limited (PME.AX) operating margin is around 0.72, and net profit margin is approximately 0.53 as of the latest reports.

In what way does PME.AX's earnings per share (EPS) trend reflect its financial momentum?

Pro Medicus Limited (PME.AX) EPS is 0.93 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Pro Medicus Limited is 337.62, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Pro Medicus Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Pro Medicus Limited like P/E which is 333.74, P/B which is 147.59, and PEG which is 17.80. Compare them with sector averages to evaluate if the stock is priced fairly.

Pro Medicus Limited

PME.AX•ASX

Healthcare

Medical - Healthcare Information Services

A$313.99

A$-7.90(-2.45%)

Pro Medicus Limited (PME.AX) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.93

P/E Ratio

337.62

ROE

0.48%

Net Margin

0.53%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$32.80B

Shares OutstandingTotal number of shares issued

$104.46M

Book Value/ShareNet worth per share

$2.13

Revenue/ShareAnnual revenue per share

$1.77

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.93

Net MarginNet income as percentage of revenue

53.25%

Operating MarginOperating income as percentage of revenue

72.19%

ROEReturn on shareholders' equity

47.95%

ROAReturn on total assets

33.41%

ROCEReturn on capital employed

51.21%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.00

Cash/ShareCash and equivalents per share

$1.75

FCF YieldFree cash flow as percentage of market cap

0.32%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.47

Dividend YieldAnnual dividend as percentage of stock price

0.15%

Financial Ratios Analysis data is not available for PME.AXFinancial Ratios Analysis details for PME.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PME.AXSector Benchmarking details for PME.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Pro Medicus Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Pro Medicus Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Pro Medicus Limited's unique business strengths and challenges.

Key Financial Metrics for Pro Medicus Limited

For Pro Medicus Limited, essential financial indicators include EPS 0.93, PE 337.62, and ROE 0.48. These key ratios reveal insights into Pro Medicus Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Pro Medicus Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Pro Medicus Limited

Metrics like Net Margin 53.25% and ROA 33.41% shed light on how well Pro Medicus Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Pro Medicus Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Pro Medicus Limited

Using ratios such as P/B Ratio 147.59 and PEG Ratio 17.80, investors can assess whether Pro Medicus Limited is appropriately valued based on its financials and growth potential. These figures, combined with Pro Medicus Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Pro Medicus Limited

Financial health indicators, such as Debt/Equity Ratio 0.008 and Cash Flow $1.00, provide a snapshot of Pro Medicus Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Pro Medicus Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Pro Medicus Limited

Investing in Pro Medicus Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Pro Medicus Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;